Antibodies to ß adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syn

Cort, trying to understand all these autoantibody studies. The above study published in Science direct, and others surrounding Rituximab, sounds like a subset of patients have autoantibodies against adrenergic and muscarinic receptors. In 2015 they found increased autoantibodies against adrenergic receptors in people with Pots? This subset had a high chance of going into remission from taking the drug Rituximab. My question for you and anyone else is, since I take a cholinergic blocker Procyclidine to stop muscle spasms and muscle twisting everywhere on my body, would that make me a good candidate to have autoantibodies against these receptors? I also have M.E. Plus, POTS, etc.
http://www.sciencedirect.com/science/article/pii/S0889159115300209
I also have no affiliation with the makers of Procyclidine or Rituximab.
 

Forum Tips

Support Our Work

DO IT MONTHLY

HEALTH RISING IS NOT A 501 (c) 3 NON-PROFIT

Shopping on Amazon.com For HR

Latest Resources

Top